AHA 2005

Aggressive Statins: the IDEAL Treatment

Terje Pedersen
Terje Pedersen

More evidence for the benefits of aggressive lipid-lowering with statins has come from the IDEAL study, which randomised nearly 9000 post-MI patients to either 80 mg of atorvastatin or 20/40 mg simvastatin daily. Terje Pedersen from Ulleval University Hospital in Norway presented the findings.

Click here for all the interviews from AHA 2005

Similar Interviews

  • Acute Coronary Syndromes: Big Mortality Reduction from Early Aggressive Statins
  • Anthony Bavry, The Cleveland ClinIc, OH American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 821-5 All cause

  • Statins Protect Heart Patients from Sepsis
  • Donald Redelmeier, University of Toronto Abstract: Lancet 2006; 367:413 Treatment with the lipid lowering agents statins reduced the incidence of sepsis among

  • Statins: It’s the LDL, Stupid!
  • In addition to lipid levels, statins are known to have anti-inflammatory, anti-thrombotic and immunomodulatory effects which could help explain their

    Post a comment

    Subscribe to Audio Medica Podcast